Fig. 2
From: Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Cox regression survival curves for patients with MCI and different constellations of CSF Aβ42 and neuronal injury markers (p-Tau and t-Tau). MCI Non+ MCI without positive CSF biomarkers, MCI Aβ+ MCI with positive Aβ42 and negative or borderline p-Tau and t-Tau, MCI Aβ+T+ MCI with positive Aβ42 and positive t-Tau or p-Tau, MCI All+ MCI with Aβ42 and both t-Tau and p-Tau positive, MCI T+ MCI with negative or borderline Aβ42 and at least p-Tau or t-Tau positive